お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
市場調査レポート
商品コード
921273

ティッシュエンジニアリング市場 - 成長、傾向、予測

Tissue Engineering Market - Growth, Trends, and Forecasts (2020 - 2025)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 113 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.61円
ティッシュエンジニアリング市場 - 成長、傾向、予測
出版日: 2020年06月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 113 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

ティッシュエンジニアリング市場は、慢性疾患、交通事故、外傷の発生率の増加、3Dティッシュエンジニアリングの技術進歩、および組織再生のための継続的な調査により、急速な成長を示しています。

当レポートでは、ティッシュエンジニアリングの世界市場を調査し、市場の概要、タイプ、地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場のダイナミクス

  • 市場概要
  • 成長要因
  • 抑制要因
  • ファイブフォース分析
    • 新規参入の脅威
    • 消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界内での競争

第5章 市場セグメンテーション

  • 素材別
    • 合成素材
    • 生物由来物質
    • その他
  • 適用別
    • 整形外科
    • 筋骨格系および脊椎
    • 神経学
    • 循環器および血管
    • 皮膚および外皮
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Allergan Plc
    • Integra Lifesciences
    • CR Bard
    • Zimmer Biomet
    • Organogenesis
    • Osiris Therapeutics
    • Biotime Inc.
    • B. Braun Melsungen AG
    • Bio Tissue Technologies

第7章 市場機会および将来動向

目次
Product Code: 67609

The tissue engineering market will show rapid growth due to the increasing incidences of chronic diseases, road accidents, and trauma injuries, technological advancements in 3d tissue engineering, and ongoing research for tissue regeneration.

The rising chronic diseases, road accidents, and trauma injuries are found to be contributing to the growth in the development of tissue engineering solutions. There is increasing number of people in need of bone implants that are on the rise owing to the increasing cases of chronic diseases, trauma cases, and growing average life span.

Furthermore, there is also a demand for relatively cheap and available skin-replacement products that have encouraged many research groups worldwide to focus on creating biomaterials for skin substitution. The engineered tissues not only closes wounds but also stimulates the regeneration of the dermis and would provide a significant benefit in human wound healing. Moreover, the increasing prevalence of chronic diseases alongside road accidents, injuries, and trauma cases escalates the market on the global platform.

Key Market Trends

Cardiology & Vascular Segment is Expected to Show the Fastest Growth During the Forecast Period

Cardiology and the vascular segment are likely to grow at the fastest rate in the coming years, due to the rapidly rising incidence rate of cardiovascular diseases and lifestyle changes. According to the American College of Cardiology, cardiovascular disease (CVD) accounted for 800,000 deaths in the United States in 2017 alone. Among Americans, an average of one person dies from cardiovascular disease, every 40 seconds.

There is a rising number of replacements as well as reconstructive surgeries that have favored the industry growth. Despite various technological advancements in this field, cardiovascular disorders are one of the leading causes of death globally. There are advancements in tissue engineering also that are likely to boost the market growth.

Asia-pacific is Expected to Record a High Growth During the Forecast Period

Asia Pacific regional segment is expected to witness the fastest growth over the forecast period, due to the increasing demand for regenerative medicines. There is also growth in medical tourism that helps to accelerate market growth. Moreover, the growing burden and changing lifestyle is also projected to significantly impact market growth over the forecast period. In Asia, more than 1 in 5 cardiovascular diseases, such as heart attack and stroke, results from smoking. The Heart Foundation states that CVD is a major cause of death in Australia, with 43,477 deaths attributed to CVD in 2017.

Furthermore, the market is also increasing due to the rising biomaterial-based research, increasing demand for plastic surgeries, a growing number of cancer incidences and the increasing prevalence of cardiovascular diseases.

Competitive Landscape

There has been a presence of a considerable number of companies that are significantly contributing to market growth. These companies' new product developments, mergers, and acquisitions are some of the strategies undertaken by these companies to strengthen their market presence. Also, there are many companies that are upgrading their product portfolios in order to meet the current demand.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase Incidences of Chronic Diseases, Road Accidents, and Trauma Injuries
    • 4.2.2 Technological Advancements in 3D Tissue Engineering
    • 4.2.3 Increase in Funding and Research for Tissue Regeneration
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Treatments Related to Tissue Engineering
    • 4.3.2 Lack of Awareness Regarding Tissue Engineering
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Material
    • 5.1.1 Synthetic Materials
    • 5.1.2 Biologically Derived Materials
    • 5.1.3 Others
  • 5.2 By Application
    • 5.2.1 Orthopedics
    • 5.2.2 Musculoskeletal & Spine
    • 5.2.3 Neurology
    • 5.2.4 Cardiology & Vascular
    • 5.2.5 Skin & Integumentary
    • 5.2.6 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AbbVie Inc. (Allergan)
    • 6.1.2 Integra Lifesciences
    • 6.1.3 Becton, Dickinson and Company (C. R. Bard)
    • 6.1.4 Zimmer Biomet
    • 6.1.5 Organogenesis
    • 6.1.6 Osiris Therapeutics
    • 6.1.7 Biotime Inc.
    • 6.1.8 B. Braun Melsungen AG
    • 6.1.9 Bio Tissue Technologies

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.